Article révisé par les pairs
Titre:
  • HER2-overexpressing breast cancer: time for the cure with less chemotherapy?
Auteur:Loi, Sherene; Azambuja, Evandro; Pugliano, Lina; Sotiriou, Christos; Piccart-Gebhart, Martine
Informations sur la publication:Current opinion in oncology, 23, 6, page (547-558)
Statut de publication:Publié, 2011-11
Sujet CREF:Cancérologie
Mots-clés:breast cancer
human epidermal growth factor 2 (HER2)
neoadjuvant
MeSH keywords:Animals
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Breast Neoplasms -- drug therapy -- enzymology
Female
Humans
Mammary Neoplasms, Experimental -- drug therapy -- enzymology
Molecular Targeted Therapy
Protein Kinase Inhibitors -- administration & dosage
Receptor, erbB-2 -- antagonists & inhibitors -- biosynthesis
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Review
SCOPUS: re.j
Langue:Anglais
Identificateurs:urn:issn:1040-8746
info:doi/10.1097/CCO.0b013e32834bd4c9
info:scp/80054103145
info:pmid/21918439